tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IPSC Stock Latest News

Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
The FlyCentury Therapeutics price target lowered to $4 from $12 at Piper Sandler
3d ago
BMY
IPSC
Century Therapeutics Faces Termination of BMS Agreement
PremiumCompany Announcements
Century Therapeutics Faces Termination of BMS Agreement
19d ago
8K
IPSC
Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults
PremiumCompany Announcements
Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults
2M ago
IPSC
Century Therapeutics price target lowered to $11 from $17 at Chardan
PremiumThe Fly
Century Therapeutics price target lowered to $11 from $17 at Chardan
2M ago
IPSC
Century Therapeutics price target lowered to $5 from $9 at H.C. Wainwright
PremiumThe Fly
Century Therapeutics price target lowered to $5 from $9 at H.C. Wainwright
2M ago
IPSC
Century Therapeutics Reports Q3 Results & Strategic Updates
PremiumCompany AnnouncementsCentury Therapeutics Reports Q3 Results & Strategic Updates
2M ago
IPSC
Century Therapeutics reports Q3 EPS (37c), consensus (45c)
Premium
The Fly
Century Therapeutics reports Q3 EPS (37c), consensus (45c)
2M ago
IPSC
Century Therapeutics expects cash to support operations into 2H26
Premium
The Fly
Century Therapeutics expects cash to support operations into 2H26
2M ago
IPSC
Century Therapeutics sees FY24 GAAP operating expenses $150M-$160M
PremiumThe Fly
Century Therapeutics sees FY24 GAAP operating expenses $150M-$160M
2M ago
IPSC
Century Therapeutics Appoints Morgan Conn as New CFO
PremiumCompany Announcements
Century Therapeutics Appoints Morgan Conn as New CFO
3M ago
8K
IPSC
Century Therapeutics appoints Conn as CFO, Cowan as CSO
PremiumThe Fly
Century Therapeutics appoints Conn as CFO, Cowan as CSO
3M ago
IPSC
Century Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
PremiumThe Fly
Century Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
5M ago
IPSC
Century Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyCentury Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
IPSC
Century Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Century Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
IPSC
Century Therapeutics Provides Investor Meeting Slide Update
Premium
Company Announcements
Century Therapeutics Provides Investor Meeting Slide Update
5M ago
8K
IPSC
Century Therapeutics reports Q2 EPS (38c), consensus (46c)
PremiumThe Fly
Century Therapeutics reports Q2 EPS (38c), consensus (46c)
5M ago
IPSC
Century Therapeutics files to sell 7.87M shares of common stock for holders
PremiumThe Fly
Century Therapeutics files to sell 7.87M shares of common stock for holders
7M ago
IPSC
Century Therapeutics price target raised to $12 from $9 at Piper Sandler
PremiumThe Fly
Century Therapeutics price target raised to $12 from $9 at Piper Sandler
7M ago
IPSC
Century Therapeutics presents interim results from Phase 1 ELiPSE-1 study
PremiumThe Fly
Century Therapeutics presents interim results from Phase 1 ELiPSE-1 study
7M ago
IPSC
Century Therapeutics files to sell 15.87M shares of common stock for holders
PremiumThe FlyCentury Therapeutics files to sell 15.87M shares of common stock for holders
8M ago
IPSC
Century announces two presentations on CNTY-101 at ASGCT 27th Annual Meeting
Premium
The Fly
Century announces two presentations on CNTY-101 at ASGCT 27th Annual Meeting
8M ago
IPSC
Century Therapeutics price target lowered to $11 from $13 at H.C. Wainwright
Premium
The Fly
Century Therapeutics price target lowered to $11 from $13 at H.C. Wainwright
8M ago
IPSC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >